Role of the carotid chemoreceptors in insulin-mediated sympathoexcitation in humans.
We examined the contribution of the carotid chemoreceptors to insulin-mediated increases in muscle sympathetic nerve activity (MSNA) in healthy humans. We hypothesized reductions in carotid chemoreceptor activity would attenuate the sympathoexcitatory response to hyperinsulinemia. Young, healthy adults (9M/9F, 28±1 yrs, 24±1 kg/m2) completed a 30-min euglycemic baseline followed by a 90-min hyperinsulinemic (1 mU/kg FFM/min), euglycemic infusion. MSNA (microneurography of the peroneal nerve) was continuously measured. The role of the carotid chemoreceptors was assessed at baseline and during hyperinsulinemia via: 1) acute hyperoxia, 2) low-dose dopamine (1-4 µg/kg/min), and 3) acute hyperoxia + low-dose dopamine. MSNA burst frequency increased from baseline during hyperinsulinemia (p<0.01). Acute hyperoxia had no effect on MSNA burst frequency at rest (p=0.74) or during hyperinsulinemia (p=0.83). The insulin-mediated increase MSNA burst frequency (p=0.02) was unaffected by low-dose dopamine (p=0.60). When combined with low-dose dopamine, acute hyperoxia had no effect on MSNA burst frequency at rest (p=0.17) or during hyperinsulinemia (p=0.85). Carotid chemoreceptor desensitization in young, healthy men and women does not attenuate the sympathoexcitatory response to hyperinsulinemia. Our data suggest the carotid chemoreceptors do not contribute to acute insulin-mediated increases in MSNA in young, healthy adults.